The price of NEUE is predicted to go up -34.29%, based on the high correlation periods with POCI. The similarity of these two price pattern on the periods is 99.88%.
NEUE
POCI
Down: -34.29%Similarity: 99.88%
NEUE Revenue Forecast
NEUE EPS Forecast
NEUE FAQs
What is bull’s view on NEUE?
NEUE stock closed at $7.31 on January 31, 2025, down 0.41% during regular trading. Analysts from RBC Capital recently lowered their price target to $7, citing valuation adjustments despite solid Q3 results. Bullish sentiment may focus on its potential privatization deal, but insider sales and mixed institutional activity suggest caution.
What is bear's view on NEUE?
NEUE stock is bearish due to insider selling and mixed institutional sentiment. The Chief Accounting Officer recently sold 18.7% of his holdings, and all insider trades in the past six months have been sales, signaling a lack of confidence. Additionally, the stock price of $7.33 is near the reduced price target of $7 by RBC Capital, reflecting limited upside potential.
What is NEUE revenue forecast for next quarter?
The market consensus for NEUE's revenue in the upcoming quarter is projected to be approximately $270.1M USD.
What is NEUE eps forecast for next quarter?
The market consensus for NEUE's eps in the upcoming quarter is projected to be approximately $4.18 USD.
RBC Capital analyst Ben Hendrix lowered the firm's price target on NeueHealth to $7 from $8 and keeps a Sector Perform rating on the shares. The company reported solid Q3 results ahead of expectations and the management maintained guidance, though the firm is reducing its price target as it rolls its valuation out to 2025, the analyst tells investors in a research note.